Hans Christian Reinhardt

29PUBLICATIONS
290CO-AUTHORS
AutoimmunityBiomechanical engineeringPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 27, 2026
Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties.

|Jul 01, 2026
Feasibility and safety of rapid glofitamab ramp-up.

|Jun 19, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL).

|Jun 02, 2026
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis.

|May 28, 2026
CSNK1E as a key to unlocking drug persistence in DLBCL.

|Apr 23, 2026
Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis.

Pageof 5

Frequent Collaborators

6 joint publications

Bastian von Tresckow

6 joint publications

Filippo Beleggia

5 joint publications

Johannes Brägelmann

5 joint publications

Martin Peifer